AEON Biopharma Inc

AEON Biopharma pivots from neuro‑toxin research to AI‑driven crypto payments, sparking investor debate on whether its biotech roots can fuel a fintech future.

AEON Biopharma Inc. is a clinical-stage biopharmaceutical company that has recently expanded into crypto payments and launched a humanoid robot, AEON, for industrial applications.